Thomas Jefferson University

Masumi Eto

TitleAssoc Prof CHP
InstitutionThomas Jefferson University
DepartmentNursing - Undergraduate
Phone215-503-7892
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tanaka Y, Ito SI, Honma Y, Hasegawa M, Kametani F, Suzuki G, Kozuma L, Takeya K, Eto M. Dysregulation of the Progranulin-driven Autophagy-lysosomal Pathway Mediates Secretion of the Nuclear Protein TDP-43. J Biol Chem. 2023 Sep 20; 105272. PMID: 37739033.
      Citations:    
    2. Youn EK, Cho HM, Jung JK, Yoon GE, Eto M, Kim JI. Pathologic HDAC1/c-Myc signaling axis is responsible for angiotensinogen transcription and hypertension induced by high-fat diet. Biomed Pharmacother. 2023 Aug; 164:114926. PMID: 37244179.
      Citations:    
    3. Pasapera AM, Heissler SM, Eto M, Nishimura Y, Fischer RS, Thiam HR, Waterman CM. MARK2 regulates directed cell migration through modulation of myosin II contractility and focal adhesion organization. Curr Biol. 2022 May 16. PMID: 35594862.
      Citations:    
    4. Tanaka Y, Hino H, Takeya K, Eto M. Abemaciclib and Vacuolin-1 induce vacuole-like autolysosome formation - A new tool to study autophagosome-lysosome fusion. Biochem Biophys Res Commun. 2022 May 14; 614:191-197. PMID: 35598430.
      Citations:    
    5. Tanaka Y, Kusumoto SY, Honma Y, Takeya K, Eto M. Overexpression of progranulin increases pathological protein accumulation by suppressing autophagic flux. Biochem Biophys Res Commun. 2022 06 30; 611:78-84. PMID: 35483222.
      Citations:    
    6. Eto M, Katsuki S, Ohashi M, Miyagawa Y, Tanaka Y, Takeya K, Kitazawa T. Possible roles of N- and C-terminal unstructured tails of CPI-17 in regulating Ca2+ sensitization force of smooth muscle. J Smooth Muscle Res. 2022; 58(0):22-33. PMID: 35418530.
      Citations:    
    7. Kitazawa T, Matsui T, Katsuki S, Goto A, Akagi K, Hatano N, Tokumitsu H, Takeya K, Eto M. A temporal Ca2+ desensitization of myosin light chain kinase in phasic smooth muscles induced by CaMKKß/PP2A pathways. Am J Physiol Cell Physiol. 2021 09 01; 321(3):C549-C558. PMID: 34106787.
      Citations:    
    8. Eto M, Katsuki S, Tanaka Y, Takeya K. Kinase activity-tagged western blotting assay. Biotechniques. 2020 Jan 15. PMID: 31939317.
      Citations:    
    9. Artamonov MV, Sonkusare SK, Good ME, Momotani K, Eto M, Isakson BE, Le TH, Cope EL, Derewenda ZS, Derewenda U, Somlyo AV. RSK2 contributes to myogenic vasoconstriction of resistance arteries by activating smooth muscle myosin and the Na+/H+ exchanger. Sci Signal. 2018 Oct 30; 11(554). PMID: 30377223.
      Citations:    
    10. Takai A, Eto M, Hirano K, Takeya K, Wakimoto T, Watanabe M. Correction to: Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology. J Physiol Sci. 2018 Mar; 68(2):201. PMID: 29181704.
      Citations:    
    11. Takai A, Eto M, Hirano K, Takeya K, Wakimoto T, Watanabe M. Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology. J Physiol Sci. 2017 Jul 05. PMID: 28681362.
      Citations:    
    12. Filter JJ, Williams BC, Eto M, Shalloway D, Goldberg ML. Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1). Elife. 2017 04 07; 6. PMID: 28387646.
      Citations:    
    13. Eto M, Kitazawa T. Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction. J Smooth Muscle Res. 2017; 53(0):1-19. PMID: 28260704.
      Citations:    
    14. Siegman MJ, Eto M, Butler TM. Remodeling of the rat distal colon in diabetes: function and ultrastructure. Am J Physiol Cell Physiol. 2016 Jan 15; 310(2):C151-60. PMID: 26561639.
      Citations:    
    15. Zhao Y, Shapiro SS, Eto M. F-actin clustering and cell dysmotility induced by the pathological W148R missense mutation of filamin B at the actin-binding domain. Am J Physiol Cell Physiol. 2016 Jan 1; 310(1):C89-98. PMID: 26491051.
      Citations:    
    16. Khasnis M, Nakatomi A, Gumpper K, Eto M. Reconstituted Human Myosin Light Chain Phosphatase Reveals Distinct Roles of Two Inhibitory Phosphorylation Sites of the Regulatory Subunit, MYPT1. Biochemistry. 2014 Apr 29; 53(16):2701-9. PMID: 24712327.
      Citations:    
    17. Eto M, Kirkbride JA, Chugh R, Karikari NK, Kim JI. Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells. Biochem Biophys Res Commun. 2013 Apr 26; 434(1):137-42. PMID: 23541585.
      Citations:    
    18. Eto M, Brautigan DL. Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling. IUBMB Life. 2012 Sep; 64(9):732-9. PMID: 22815089.
      Citations:    
    19. Tazzeo T, Bates G, Roman HN, Lauzon AM, Khasnis MD, Eto M, Janssen LJ. Caffeine relaxes smooth muscle through actin depolymerization. Am J Physiol Lung Cell Mol Physiol. 2012 Aug 15; 303(4):L334-42. PMID: 22683573.
      Citations:    
    20. Khromov AS, Momotani K, Jin L, Artamonov MV, Shannon J, Eto M, Somlyo AV. Molecular mechanism of telokin-mediated disinhibition of myosin light chain phosphatase and cAMP/cGMP-induced relaxation of gastrointestinal smooth muscle. J Biol Chem. 2012 Jun 15; 287(25):20975-85. PMID: 22544752.
      Citations:    
    21. Kim JI, Urban M, Young GD, Eto M. Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2012 Jul 1; 303(1):C58-68. PMID: 22538237.
      Citations:    
    22. Grindrod S, Suy S, Fallen S, Eto M, Toretsky J, Brown ML. Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cells. Front Oncol. 2011; 1:27. PMID: 22655237.
      Citations:    
    23. Terai M, Eto M, Young GD, Berd D, Mastrangelo MJ, Tamura Y, Harigaya K, Sato T. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma. Cancer Immunol Immunother. 2012 Feb; 61(2):145-55. PMID: 21853302.
      Citations:    
    24. Kim JI, Jung SW, Yang E, Park KM, Eto M, Kim IK. Heat shock augments angiotensin II-induced vascular contraction through increased production of reactive oxygen species. Biochem Biophys Res Commun. 2010 Aug 27; 399(3):452-7. PMID: 20688045.
      Citations:    
    25. Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J Biol Chem. 2009 Dec 18; 284(51):35273-7. PMID: 19846560.
      Citations:    
    26. Mori S, Iwaoka R, Eto M, Ohki SY. Solution structure of the inhibitory phosphorylation domain of myosin phosphatase targeting subunit 1. Proteins. 2009 Nov 15; 77(3):732-5. PMID: 19701943.
      Citations:    
    27. Xiao L, Eto M, Kazanietz MG. ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK. J Biol Chem. 2009 Oct 23; 284(43):29365-75. PMID: 19667069.
      Citations:    
    28. Khromov A, Choudhury N, Stevenson AS, Somlyo AV, Eto M. Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction. J Biol Chem. 2009 Aug 7; 284(32):21569-79. PMID: 19531490.
      Citations:    
    29. Kitazawa T, Semba S, Huh YH, Kitazawa K, Eto M. Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1. J Physiol. 2009 Jul 15; 587(Pt 14):3587-603. PMID: 19470783.
      Citations:    
    30. Kim JI, Young GD, Jin L, Somlyo AV, Eto M. Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation. Histochem Cell Biol. 2009 Aug; 132(2):191-8. PMID: 19437030.
      Citations:    
    31. Freitas MR, Eto M, Kirkbride JA, Schott C, Sassard J, Stoclet JC. Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle. Fundam Clin Pharmacol. 2009 Apr; 23(2):169-78. PMID: 19298234.
      Citations:    
    32. Neppl RL, Lubomirov LT, Momotani K, Pfitzer G, Eto M, Somlyo AV. Thromboxane A2-induced bi-directional regulation of cerebral arterial tone. J Biol Chem. 2009 Mar 6; 284(10):6348-60. PMID: 19095646.
      Citations:    
    33. Eto M, Kitazawa T, Matsuzawa F, Aikawa S, Kirkbride JA, Isozumi N, Nishimura Y, Brautigan DL, Ohki SY. Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor. Structure. 2007 Dec; 15(12):1591-602. PMID: 18073109.
      Citations:    
    34. Eto M, Kirkbride J, Elliott E, Lo SH, Brautigan DL. Association of the tensin N-terminal protein-tyrosine phosphatase domain with the alpha isoform of protein phosphatase-1 in focal adhesions. J Biol Chem. 2007 Jun 15; 282(24):17806-15. PMID: 17435217.
      Citations:    
    35. Eto M, Brautigan DL. Assay for three-way interaction of protein phosphatase-1 (Glc7) with regulatory subunits plus phosphatase inhibitor-2. Methods Mol Biol. 2007; 365:197-208. PMID: 17200563.
      Citations:    
    36. Dimopoulos GJ, Semba S, Kitazawa K, Eto M, Kitazawa T. Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle. Circ Res. 2007 Jan 5; 100(1):121-9. PMID: 17158339.
      Citations:    
    37. Woodsome TP, Polzin A, Kitazawa K, Eto M, Kitazawa T. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J Cell Sci. 2006 May 1; 119(Pt 9):1769-80. PMID: 16608882.
      Citations:    
    38. Eto M, Kirkbride JA, Brautigan DL. Assembly of MYPT1 with protein phosphatase-1 in fibroblasts redirects localization and reorganizes the actin cytoskeleton. Cell Motil Cytoskeleton. 2005 Oct; 62(2):100-9. PMID: 16106448.
      Citations:    
    39. Eto M, Yazawa M. [Function and regulation of Ser/Thr-specific protein phosphatase-1 (PP1)]. Seikagaku. 2005 Oct; 77(10):1308-16. PMID: 16296323.
      Citations:    
    40. Matsuzawa F, Aikawa SI, Ohki SY, Eto M. Phospho-pivot modeling predicts specific interactions of protein phosphatase-1 with a phospho-inhibitor protein CPI-17. J Biochem. 2005 May; 137(5):633-41. PMID: 15944417.
      Citations:    
    41. Pang H, Guo Z, Su W, Xie Z, Eto M, Gong MC. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2005 Aug; 289(2):C352-60. PMID: 15814590.
      Citations:    
    42. Stevenson AS, Matthew JD, Eto M, Luo S, Somlyo AP, Somlyo AV. Uncoupling of GPCR and RhoA-induced Ca2+-sensitization of chicken amnion smooth muscle lacking CPI-17. FEBS Lett. 2004 Dec 3; 578(1-2):73-9. PMID: 15581619.
      Citations:    
    43. Eto M, Kitazawa T, Brautigan DL. Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proc Natl Acad Sci U S A. 2004 Jun 15; 101(24):8888-93. PMID: 15184667.
      Citations:    
    44. Kitazawa T, Polzin AN, Eto M. CPI-17-deficient smooth muscle of chicken. J Physiol. 2004 Jun 1; 557(Pt 2):515-28. PMID: 15090608.
      Citations:    
    45. Murthy KS, Zhou H, Grider JR, Brautigan DL, Eto M, Makhlouf GM. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway. Biochem J. 2003 Aug 15; 374(Pt 1):145-55. PMID: 12733988.
      Citations:    
    46. Erdodi F, Kiss E, Walsh MP, Stefansson B, Deng JT, Eto M, Brautigan DL, Hartshorne DJ. Phosphorylation of protein phosphatase type-1 inhibitory proteins by integrin-linked kinase and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun. 2003 Jun 27; 306(2):382-7. PMID: 12804574.
      Citations:    
    47. Ohki Sy, Eto M, Shimizu M, Takada R, Brautigan DL, Kainosho M. Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threonine residue. J Mol Biol. 2003 Mar 7; 326(5):1539-47. PMID: 12595264.
      Citations:    
    48. Somlyo AV, Phelps C, Dipierro C, Eto M, Read P, Barrett M, Gibson JJ, Burnitz MC, Myers C, Somlyo AP. Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants. FASEB J. 2003 Feb; 17(2):223-34. PMID: 12554701.
      Citations:    
    49. Kitazawa T, Eto M, Woodsome TP, Khalequzzaman M. Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle. J Physiol. 2003 Feb 1; 546(Pt 3):879-89. PMID: 12563012.
      Citations:    
    50. Eto M, Leach C, Tountas NA, Brautigan DL. Phosphoprotein inhibitors of protein phosphatase-1. Methods Enzymol. 2003; 366:243-60. PMID: 14674253.
      Citations:    
    51. Eto M, Bock R, Brautigan DL, Linden DJ. Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor. Neuron. 2002 Dec 19; 36(6):1145-58. PMID: 12495628.
      Citations:    
    52. Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem J. 2002 Oct 15; 367(Pt 2):517-24. PMID: 12144526.
      Citations:    
    53. Leach C, Eto M, Brautigan DL. Domains of type 1 protein phosphatase inhibitor-2 required for nuclear and cytoplasmic localization in response to cell-cell contact. J Cell Sci. 2002 Oct 1; 115(Pt 19):3739-45. PMID: 12235284.
      Citations:    
    54. Eto M, Elliott E, Prickett TD, Brautigan DL. Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation. J Biol Chem. 2002 Nov 15; 277(46):44013-20. PMID: 12221103.
      Citations:    
    55. Broustas CG, Grammatikakis N, Eto M, Dent P, Brautigan DL, Kasid U. Phosphorylation of the myosin-binding subunit of myosin phosphatase by Raf-1 and inhibition of phosphatase activity. J Biol Chem. 2002 Jan 25; 277(4):3053-9. PMID: 11719507.
      Citations:    
    Eto's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (287)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _